REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFD Technologies Regulatory News (FDP)

Share Price Information for FD Technologies (FDP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,310.00
Bid: 1,082.00
Ask: 1,374.00
Change: 0.00 (0.00%)
Spread: 292.00 (26.987%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,310.00
FDP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change and Appointment

24 Mar 2015 07:01

RNS Number : 2535I
First Derivatives PLC
24 March 2015
 



24 March 2015

 

First Derivatives PLC

("FD" or the "Company")

 

Directorate Change and Appointment

 

FD (AIM:FDP.L, ESM:FDP.I), a leading provider of software and consulting services, announces the appointment of Pat Brazel as Global Head of Software Sales, following the acquisition of ActivateClients Limited detailed in a separate announcement earlier today. As a result of this appointment, Mr Brazel has stepped down as a Non-Executive Director of the Company with immediate effect.

 

The appointment of Mr Brazel strengthens the Company's executive leadership as it seeks to penetrate additional vertical sectors, using the capabilities of its Delta platform and kdb+ to capture and analyse big data, especially fast streaming information. He will work alongside Gerry Buggy, who will take up a new role as Chief Technology Officer.

 

Mr Brazel has more than 25 years' experience in the software industry, including nearly a decade as President of Sungard Capital Markets. He was also a founder of Sentry Financial Technology, now part of IBM and of GoldTier Technologies, which was acquired by Thomson Reuters in 2013.

 

Pat Brazel commented: "My time as a Non-Executive Director at FD has convinced me of the Company's potential to become the leading player in the emerging market for fast data and analytics. In my new role as Global Head of Software Sales, I look forward to helping FD realise this ambition."

 

Brian Conlon, Chief Executive Officer of FD, commented: "I am delighted to announce the appointment of Pat Brazel. His track record in driving sales at high-growth enterprise software companies will be extremely valuable to the Company. We continue to invest in our sales and marketing capability to meet a range of market opportunities, particularly as we execute on our strategy to enter new vertical markets."

 

 

 

Enquiries:

First Derivatives plc

Brian Conlon, Chief Executive Officer

Graham Ferguson, Finance Director

Ian Mitchell, Head of Investor Relations

+44(0)28 3025 2242

www.firstderivatives.com

Charles Stanley Securities

(Nominated Adviser and Broker)

Russell Cook

Carl Holmes

+44 (0)20 7149 6000

Goodbody Corporate Finance

(ESM Adviser and Broker)

Linda Hickey

+353 1 667 0420

Walbrook PR

Paul Cornelius

Sam Allen

Nick Rome

+44 (0)20 7933 8780

 

 

 

About First Derivatives

FD is a global technology provider with nearly 20 years of experience of working with some of the world's largest finance, technology and energy institutions. It holds a 65% stake in Palo Alto-based Kx Systems, developer of the world-leading database technology, kdb+. It employs over 1,200 people worldwide and has operations in London, New York, Stockholm, Singapore, Hong Kong, Tokyo, Sydney, Toronto, Philadelphia, Dublin, Belfast and its headquarters in Newry. For further information, please visit www.firstderivatives.com.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAUSRARVWAOURR
Date   Source Headline
2nd Sep 20207:00 amRNSTotal Voting Rights
26th Aug 20208:46 amRNSIssue of Equity
20th Aug 20206:10 pmRNSHolding(s) in Company
6th Aug 20207:00 amRNSEuronext Growth Dublin Notice
31st Jul 202012:01 pmRNSIssue of Equity and Total Voting Rights
20th Jul 20207:00 amRNSAppointment of Kx Chief Revenue Officer
14th Jul 20207:00 amRNSDirectorate Change
9th Jul 20207:00 amRNSShare Option Plan Awards
9th Jul 20207:00 amRNSEuronext Growth Dublin Notice
8th Jul 20204:07 pmRNSResult of AGM
8th Jul 20207:00 amRNSAGM Statement
7th Jul 202012:02 pmRNSPrice Monitoring Extension
6th Jul 20207:00 amRNSSenior Executive Appointment
3rd Jul 202010:23 amRNSIssue of Equity
2nd Jul 20207:00 amRNSDirectorate Change
30th Jun 20202:35 pmRNSTotal Voting Rights
9th Jun 20208:00 amRNSEuronext Growth Dublin Notice
8th Jun 20204:30 pmRNSNotice of AGM
3rd Jun 20202:33 pmRNSIssue of Equity
1st Jun 202011:00 amRNSTotal Voting Rights
28th May 20207:00 amRNSEuronext Growth Dublin Notice
22nd May 20205:59 pmRNSIssue of Equity - Correction
21st May 20204:19 pmRNSIssue of Equity
19th May 20207:00 amRNSGlobal partnership agreement
19th May 20207:00 amRNSFull year results for the year ended 29 Feb 2020
9th Apr 20207:00 amRNSTrading Statement
31st Mar 202010:06 amRNSTotal Voting Rights
12th Mar 20207:00 amRNSEuronext Growth Dublin Notice
6th Mar 202010:52 amRNSIssue of Equity
17th Feb 20207:00 amRNSMajor oilfield services contract win
31st Jan 202012:01 pmRNSTotal Voting Rights
30th Jan 20207:00 amRNSEuronext Growth Dublin Notice
24th Jan 20202:01 pmRNSIssue of Equity
15th Jan 20207:00 amRNSCEO appointment and Board changes
31st Dec 20199:58 amRNSTotal Voting Rights
17th Dec 20197:00 amRNSEuronext Growth Dublin Notice
12th Dec 20197:00 amRNSEuronext Growth Dublin Notice
11th Dec 20193:10 pmRNSIssue of Equity
11th Dec 20197:50 amRNSHolding(s) in Company
6th Dec 20193:10 pmRNSIssue of Equity
29th Nov 20194:46 pmRNSTotal Voting Rights
15th Nov 20197:00 amRNSEuronext Growth Dublin Notice
8th Nov 20192:32 pmRNSIssue of Equity
5th Nov 20197:00 amRNSInterim results for the six months ended 31.08.19
1st Nov 201910:15 amRNSHolding(s) in Company
8th Oct 20197:00 amRNSNotice of Results
30th Sep 20191:20 pmRNSTotal Voting Rights
9th Sep 20197:00 amRNSEuronext Growth Dublin Notice
3rd Sep 20194:09 pmRNSIssue of Equity
2nd Sep 20194:35 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.